Liquidia Corporation $LQDA Shares Bought by Seven Fleet Capital Management LP

Seven Fleet Capital Management LP lifted its position in shares of Liquidia Corporation (NASDAQ:LQDA) by 25.2% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 256,603 shares of the company’s stock after acquiring an additional 51,727 shares during the period. Liquidia accounts for 3.4% of Seven Fleet Capital Management LP’s portfolio, making the stock its 5th biggest holding. Seven Fleet Capital Management LP owned about 0.29% of Liquidia worth $20,459,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Northwestern Mutual Wealth Management Co. acquired a new position in Liquidia during the 4th quarter valued at about $25,000. NewEdge Advisors LLC acquired a new stake in shares of Liquidia in the second quarter valued at approximately $25,000. Covestor Ltd raised its holdings in shares of Liquidia by 41.9% during the fourth quarter. Covestor Ltd now owns 1,216 shares of the company’s stock valued at $42,000 after buying an additional 359 shares during the last quarter. Tower Research Capital LLC TRC boosted its position in shares of Liquidia by 281.2% during the second quarter. Tower Research Capital LLC TRC now owns 6,679 shares of the company’s stock worth $83,000 after buying an additional 4,927 shares during the period. Finally, Globeflex Capital L P acquired a new position in shares of Liquidia during the second quarter worth approximately $175,000. Institutional investors and hedge funds own 64.54% of the company’s stock.

Analyst Ratings Changes

Several analysts have weighed in on the company. Zacks Research downgraded Liquidia from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 13th. Stephens set a $130.00 price target on Liquidia in a report on Friday, July 24th. BTIG Research lifted their price objective on shares of Liquidia from $109.00 to $111.00 and gave the company a “buy” rating in a research note on Wednesday, August 12th. Royal Bank Of Canada set a $130.00 price objective on shares of Liquidia in a report on Friday, July 24th. Finally, Piper Sandler set a $129.00 target price on shares of Liquidia in a research report on Friday, July 24th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $98.08.

Insider Activity

In related news, Director Stephen M. Bloch sold 242,269 shares of Liquidia stock in a transaction dated Thursday, June 11th. The stock was sold at an average price of $70.43, for a total transaction of $17,063,005.67. Following the transaction, the director directly owned 1,176,184 shares of the company’s stock, valued at $82,838,639.12. The trade was a 17.08% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Paul B. Manning sold 200,000 shares of the business’s stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $63.91, for a total transaction of $12,782,000.00. Following the completion of the sale, the director owned 716,311 shares in the company, valued at approximately $45,779,436.01. This trade represents a 21.83% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 1,854,286 shares of company stock valued at $131,450,837 in the last ninety days. Company insiders own 25.60% of the company’s stock.

Liquidia Stock Performance

LQDA opened at $71.36 on Thursday. The business has a 50 day moving average price of $79.36 and a two-hundred day moving average price of $56.86. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.31 and a quick ratio of 2.12. The company has a market capitalization of $6.39 billion, a price-to-earnings ratio of 52.09 and a beta of 0.58. Liquidia Corporation has a 1-year low of $21.15 and a 1-year high of $93.61.

Liquidia (NASDAQ:LQDA) last issued its quarterly earnings results on Wednesday, August 12th. The company reported $0.74 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.76 by ($0.02). Liquidia had a net margin of 30.74% and a return on equity of 149.65%. The firm had revenue of $171.68 million for the quarter, compared to analyst estimates of $168.48 million. During the same quarter last year, the business posted ($0.49) earnings per share. The firm’s revenue for the quarter was up 1842.1% compared to the same quarter last year. Research analysts predict that Liquidia Corporation will post 2.57 EPS for the current fiscal year.

Liquidia Company Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).